Loading...
CRAD B logo

C-Rad AB (publ)OM:CRAD B Stock Report

Market Cap SEK 898.2m
Share Price
SEK 26.60
n/a
1Y-17.5%
7D-5.3%
Portfolio Value
​
View

C-Rad AB (publ)

OM:CRAD B Stock Report

Market Cap: SEK 898.2m

C-Rad (CRAD B) Stock Overview

Develops, manufactures, and sells products and systems with applications in radiotherapy for the treatment of cancer in Europe, the Middle East, Africa, the Americas, and the Asia Pacific. More details

CRAD B fundamental analysis
Snowflake Score
Valuation2/6
Future Growth5/6
Past Performance2/6
Financial Health6/6
Dividends0/6

Rewards

Trading at 66.1% below our estimate of its fair value

Earnings are forecast to grow 45.53% per year

Risk Analysis

Profit margins (2.4%) are lower than last year (12%)

Does not have a meaningful market cap (SEK898M)


CRAD B Community Fair Values

Create Narrative

See what 7 others think this stock is worth. Follow their fair value or set your own to get alerts.

CRAD B logo
C-Rad

Aging Population And Healthcare Digitization Will Expand Radiotherapy Demand

Key Takeaways Rising global demand for radiotherapy and healthcare digitization position C-Rad for long-term growth, higher margins, and expanded market presence. Increased recurring service revenues and operational efficiencies are enhancing profit stability and buffering earnings against short-term fluctuations.
View narrative
SEK 35
FV
25.4% undervalued intrinsic discount
11.50%
Revenue growth p.a.
35
users have viewed this narrative
0users have liked this narrative
0users have commented on this narrative
5users have followed this narrative
View Stock Community

C-Rad AB (publ) Competitors

Price History & Performance

Summary of share price highs, lows and changes for C-Rad
Historical stock prices
Current Share PriceSEK 26.60
52 Week HighSEK 37.40
52 Week LowSEK 25.30
Beta0.87
1 Month Change-15.69%
3 Month Change-18.78%
1 Year Change-17.52%
3 Year Change-21.53%
5 Year Change-54.30%
Change since IPO77.33%

Recent News & Updates

Earnings Miss: C-Rad AB (publ) Missed EPS By 61% And Analysts Are Revising Their Forecasts

Feb 15
Earnings Miss: C-Rad AB (publ) Missed EPS By 61% And Analysts Are Revising Their Forecasts

Recent updates

Earnings Miss: C-Rad AB (publ) Missed EPS By 61% And Analysts Are Revising Their Forecasts

Feb 15
Earnings Miss: C-Rad AB (publ) Missed EPS By 61% And Analysts Are Revising Their Forecasts

Is Now An Opportune Moment To Examine C-Rad AB (publ) (STO:CRAD B)?

Nov 29
Is Now An Opportune Moment To Examine C-Rad AB (publ) (STO:CRAD B)?

C-Rad's (STO:CRAD B) Soft Earnings Are Actually Better Than They Appear

Oct 29
C-Rad's (STO:CRAD B) Soft Earnings Are Actually Better Than They Appear

Returns on Capital Paint A Bright Future For C-Rad (STO:CRAD B)

Sep 17
Returns on Capital Paint A Bright Future For C-Rad (STO:CRAD B)

Earnings Miss: C-Rad AB (publ) Missed EPS By 71% And Analysts Are Revising Their Forecasts

Jul 23
Earnings Miss: C-Rad AB (publ) Missed EPS By 71% And Analysts Are Revising Their Forecasts

Results: C-Rad AB (publ) Delivered A Surprise Loss And Now Analysts Have New Forecasts

May 09
Results: C-Rad AB (publ) Delivered A Surprise Loss And Now Analysts Have New Forecasts

Investors Continue Waiting On Sidelines For C-Rad AB (publ) (STO:CRAD B)

Apr 15
Investors Continue Waiting On Sidelines For C-Rad AB (publ) (STO:CRAD B)

C-Rad's (STO:CRAD B) Earnings Are Weaker Than They Seem

Feb 15
C-Rad's (STO:CRAD B) Earnings Are Weaker Than They Seem

Earnings Miss: C-Rad AB (publ) Missed EPS By 9.8% And Analysts Are Revising Their Forecasts

Feb 12
Earnings Miss: C-Rad AB (publ) Missed EPS By 9.8% And Analysts Are Revising Their Forecasts
User avatar

Global Expansion And SGRT Demand Will Drive Future Success

Strategic global expansion, particularly in APAC, and long-term contracts in advanced markets support revenue growth and market share increase.

Sentiment Still Eluding C-Rad AB (publ) (STO:CRAD B)

Oct 24
Sentiment Still Eluding C-Rad AB (publ) (STO:CRAD B)

Market Participants Recognise C-Rad AB (publ)'s (STO:CRAD B) Earnings Pushing Shares 29% Higher

Jun 02
Market Participants Recognise C-Rad AB (publ)'s (STO:CRAD B) Earnings Pushing Shares 29% Higher

Returns On Capital Are A Standout For C-Rad (STO:CRAD B)

Mar 01
Returns On Capital Are A Standout For C-Rad (STO:CRAD B)

C-Rad's (STO:CRAD B) Earnings Are Weaker Than They Seem

Feb 15
C-Rad's (STO:CRAD B) Earnings Are Weaker Than They Seem

Do C-Rad's (STO:CRAD B) Earnings Warrant Your Attention?

Feb 03
Do C-Rad's (STO:CRAD B) Earnings Warrant Your Attention?

C-Rad AB (publ)'s (STO:CRAD B) Popularity With Investors Is Clear

Jan 19
C-Rad AB (publ)'s (STO:CRAD B) Popularity With Investors Is Clear

Is Now The Time To Look At Buying C-Rad AB (publ) (STO:CRAD B)?

Oct 28
Is Now The Time To Look At Buying C-Rad AB (publ) (STO:CRAD B)?

Returns Are Gaining Momentum At C-Rad (STO:CRAD B)

Aug 16
Returns Are Gaining Momentum At C-Rad (STO:CRAD B)

Are Investors Undervaluing C-Rad AB (publ) (STO:CRAD B) By 45%?

Dec 14
Are Investors Undervaluing C-Rad AB (publ) (STO:CRAD B) By 45%?

Is Now An Opportune Moment To Examine C-Rad AB (publ) (STO:CRAD B)?

Jul 20
Is Now An Opportune Moment To Examine C-Rad AB (publ) (STO:CRAD B)?

Returns Are Gaining Momentum At C-Rad (STO:CRAD B)

May 07
Returns Are Gaining Momentum At C-Rad (STO:CRAD B)

Earnings Miss: C-Rad AB (publ) Missed EPS By 5.5% And Analysts Are Revising Their Forecasts

Jan 30
Earnings Miss: C-Rad AB (publ) Missed EPS By 5.5% And Analysts Are Revising Their Forecasts

Shareholder Returns

CRAD BSE Medical EquipmentSE Market
7D-5.3%1.7%1.9%
1Y-17.5%-18.8%6.6%

Return vs Industry: CRAD B matched the Swedish Medical Equipment industry which returned -18.8% over the past year.

Return vs Market: CRAD B underperformed the Swedish Market which returned 6.6% over the past year.

Price Volatility

Is CRAD B's price volatile compared to industry and market?
CRAD B volatility
CRAD B Average Weekly Movement4.2%
Medical Equipment Industry Average Movement7.4%
Market Average Movement6.1%
10% most volatile stocks in SE Market12.3%
10% least volatile stocks in SE Market3.3%

Stable Share Price: CRAD B has not had significant price volatility in the past 3 months compared to the Swedish market.

Volatility Over Time: CRAD B's weekly volatility (4%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
2004110Tomas Blomquistc-rad.com

C-Rad AB (publ) develops, manufactures, and sells products and systems with applications in radiotherapy for the treatment of cancer in Europe, the Middle East, Africa, the Americas, and the Asia Pacific. The company offers Catalyst+ HD, a patient positioning, intra-fraction motion management, and respiratory gating solution for conventional and stereotactic treatment delivery; Catalyst+, a solution for patient set up and intra-fraction breath hold reproducibility; Catalyst+ PT, a surface image guided radiation therapy solution that supports proton therapy from simulation to treatment; Catalyst+ HD Ring Gantry solution for patient positioning, real-time motion monitoring, and respiratory gating; and Sentinel 4DCT, a laser-based optical surface scanning system. It also provides Catalyst, a 4D surface guided radiation therapy (SGRT) solution; Catalyst HD, a SGRT solution on stereotactic radiation therapy for online patient tracking before and during treatment delivery; Catalyst PT, a tracking solution for particle therapy; and visual coaching solutions used for prospective and retrospective radiotherapy.

C-Rad AB (publ) Fundamentals Summary

How do C-Rad's earnings and revenue compare to its market cap?
CRAD B fundamental statistics
Market capSEK 898.20m
Earnings (TTM)SEK 10.50m
Revenue (TTM)SEK 441.90m
85.5x
P/E Ratio
2.0x
P/S Ratio

Is CRAD B overvalued?

See Fair Value and valuation analysis

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
CRAD B income statement (TTM)
RevenueSEK 441.90m
Cost of RevenueSEK 125.90m
Gross ProfitSEK 316.00m
Other ExpensesSEK 305.50m
EarningsSEK 10.50m

Last Reported Earnings

Dec 31, 2025

Next Earnings Date

May 06, 2026

Earnings per share (EPS)0.31
Gross Margin71.51%
Net Profit Margin2.38%
Debt/Equity Ratio0%

How did CRAD B perform over the long term?

See historical performance and comparison

Dividends

0.4%
Current Dividend Yield
32%
Payout Ratio

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2026/03/02 15:58
End of Day Share Price 2026/02/27 00:00
Earnings2025/12/31
Annual Earnings2025/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

C-Rad AB (publ) is covered by 2 analysts. 1 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Victor ForssellABG Sundal Collier Sponsored
Christian LeePareto Securities